Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 1

1(12.5%)

Phase 2

1(12.5%)

Phase 3

1(12.5%)

8Total

N/A(5)

Phase 1(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03913689Completed

StimRouter Registry Clinical Protocol

Role: lead

NCT02873312Not ApplicableUnknown

Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial

Role: lead

NCT03093935Not ApplicableTerminated

StimRouter™ for Pain Management in Post-stroke Shoulder Pain

Role: lead

NCT00665132Phase 1Completed

Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves

Role: lead

NCT01138995Not ApplicableCompleted

Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop

Role: lead

NCT02738242Not ApplicableUnknown

Evaluation of Usability and Human Factors in the Novus System

Role: collaborator

NCT01592344Not ApplicableCompleted

Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy

Role: lead

NCT00567541Phase 2Completed

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects

Role: lead

NCT01237860Phase 3Completed

Evaluation of the Safety and Performance of the NESS L300 Plus System

Role: lead

All 9 trials loaded